Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 50003960
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196191(N-(5-iodo-2-(morpholine-4-carbonyl)phenyl)quinoxal...)
Affinity DataKi:  32nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196157(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  40nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478086(CHEMBL261682)
Affinity DataKi:  63nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478090(CHEMBL259762)
Affinity DataKi:  79nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478094(CHEMBL408452)
Affinity DataKi:  501nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196192(1-[4-bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoy...)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478092(CHEMBL410708)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478089(CHEMBL261636)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196171(1-[2-[(2,1,3-benzooxadiazol-4-ylsulfonyl)amino]-4-...)
Affinity DataKi:  1.59E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478085(CHEMBL259224)
Affinity DataKi:  1.59E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478091(CHEMBL259751)
Affinity DataKi:  2.00E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478087(CHEMBL409479)
Affinity DataKi:  3.16E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478093(CHEMBL410905)
Affinity DataKi:  5.01E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478093(CHEMBL410905)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478091(CHEMBL259751)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478090(CHEMBL259762)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196191(N-(5-iodo-2-(morpholine-4-carbonyl)phenyl)quinoxal...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196152(N-(5-chloro-2-(piperidine-1-carbonyl)phenyl)quinol...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196171(1-[2-[(2,1,3-benzooxadiazol-4-ylsulfonyl)amino]-4-...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478094(CHEMBL408452)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196157(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196160(1-[4-bromo-2-[(isoquinolin-5-ylsulfonyl)amino]-ben...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478092(CHEMBL410708)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478088(CHEMBL412282)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196152(N-(5-chloro-2-(piperidine-1-carbonyl)phenyl)quinol...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196160(1-[4-bromo-2-[(isoquinolin-5-ylsulfonyl)amino]-ben...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478089(CHEMBL261636)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478088(CHEMBL412282)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478087(CHEMBL409479)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478086(CHEMBL261682)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196192(1-[4-bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoy...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50478085(CHEMBL259224)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2020
Entry Details Article
PubMed